Genesco (GCO) Tops Q3 EPS by 3c; Lowers Q4 EPS Guidance
Tweet
Share
E-mailGet Alerts GCO Hot Sheet
Price: $35.50 +0.97%
Revenue Growth %: -3.2%
Financial Fact:
Provision for discontinued operations, net: -53K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Revenue Growth %: -3.2%
Financial Fact:
Provision for discontinued operations, net: -53K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Genesco (NYSE: GCO) reported Q3 EPS of $1.65, $0.03 better than the analyst estimate of $1.62. Revenue for the quarter came in at $604 million versus the consensus estimate of $593.73 million.
GUIDANCE:
Genesco sees Q4 2023 EPS of $5.50-$5.90, versus the consensus of $6.44.
For earnings history and earnings-related data on Genesco (GCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- zSpace, Inc. (ZSPC) Reports Q2 results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
